An open-label, multi-center phase 2 study to assess the safety and efficacy of burixafor (GPC-100) and propranolol with G-CSF for the mobilization of stem cells in patients with multiple myeloma undergoing autologous stem cell transplant Meeting Abstract
| Authors: | Caculitan, N.; Kim, G.; Woolfrey, A.; Akard, L. P.; Jeong, A. R.; Khouri, J.; Shah, G. L.; Cardarelli, P. M. |
| Abstract Title: | An open-label, multi-center phase 2 study to assess the safety and efficacy of burixafor (GPC-100) and propranolol with G-CSF for the mobilization of stem cells in patients with multiple myeloma undergoing autologous stem cell transplant |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 4858 |
| End Page: | 4859 |
| Language: | English |
| ACCESSION: | WOS:001412523500015 |
| DOI: | 10.1182/blood-2024-208805 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
